Term ended Sep 4, 2026 · Medium confidence
20-year base term ended May 12, 2025
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,572,784), so the cap could be lower.
May 12, 2005
Sep 4, 2026
Mar 19, 2013
This patent's term runs 480 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 12, 2005, when application 11/127,855, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2009) | May 12, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +480 days, USPTO patent term adjustment record | Sep 4, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,572,784, US 8,026,246) | resolves to Sep 4, 2026, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Sep 4, 2026 | Medium confidence |
This family
| US 7,572,784 | In force no later than Dec 2027 | no later than Dec 2027 |
| US 8,026,246 | In force May 2029 | May 2029 |
| US 8,399,659 | this patent Sep 2026 | Sep 2026 |
| US 9,173,846 | In force May 2030 | May 2030 |
| Application 13/217,659 | Abandoned not computed | not computed |
| US 9,988,384 | In force Nov 2027 | Nov 2027 |
| US 9,102,678 | Term ended May 2025 | May 2025 |
| US 9,765,076 | In force Nov 2027 | Nov 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 28, 2012 Reel 29042, frame 488 | Claiborne, Christopher F.; Payne, Lloyd J.; Boyce, Richard J.; Sells, Todd B.; Stroud, Stephen G.; Travers, Stuart; Vos, Tricia J.; Weatherhead, Gabriel S. | Millennium Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 7,572,784, US 8,026,246, ends no earlier than this term, so it caps nothing.